The Food and Drug Administration today authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at least six months after receiving the initial two-dose series or two months after receiving the single-dose Johnson & Johnson vaccine.  
 
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices then recommended a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older, based on individual benefit and risk, at least six months after receiving the initial two-dose series. The CDC director will now consider that recommendation. 

Related News Articles

Headline
The Food and Drug Administration Friday authorized administering bamlanivimab and etesivimab together to treat or prevent COVID-19 in all pediatric…
Blog
To help hospitals and health system leaders stay up-to-date on all of the legal developments related to vaccine mandates, the AHA has developed a blog authored…
Headline
The House this week passed the Maternal Vaccination Act (H.R. 951), an AHA-supported provision from the Black Maternal Health Momnibus Act that would…
Headline
The Centers for Medicare & Medicaid Services will not enforce its COVID-19 vaccine mandate for health care workers while enjoined by district courts in…
Headline
The Centers for Medicare & Medicaid Services today began requiring state Medicaid programs to cover counseling visits at which health care providers…
News
A federal district court in Louisiana late yesterday issued a preliminary injunction placing a temporary hold on enforcement of the Centers for Medicare &…